| Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information. |
| |
| Device | Synvisc, Synvisc-One |
| Generic Name | Acid, hyaluronic, intraarticular |
| Applicant | Sanofi Genzyme Corp. 450 Water St. Cambridge, MA 02141 |
| PMA Number | P940015 |
| Supplement Number | S052 |
| Date Received | 12/03/2024 |
| Decision Date | 01/02/2025 |
| Product Code |
MOZ |
| Advisory Committee |
Orthopedic |
| Supplement Type | Special (Immediate Track) |
| Supplement Reason | Labeling Change - Indications/instructions/shelf life/tradename |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
| Recalls | CDRH Recalls |
Approval Order Statement Approval for revisions of the Synvisc® and Synvisc-One® physician labeling to include a precaution statement stating the device is only intended for use by healthcare professionals adequately trained to administer intra-articular injections and revisions to the Synvisc® and Synvisc-One® patient labeling to include the same advisory statement. |
|
|